Weinberg Medical Physics, LLC

NORTH BETHESDA, MD 20852

SBIR Award Summary

Total Number of Awards 33
Total Value of Awards $15.8MM
First Award Date 05/25/07
Most Recent Award Date 12/01/17

Key Personnel

Last Name Name Awards Contact
Weinberg Irving Weinberg 24 Message
Fricke Stanley Thomas Fricke 8
Probst Roland Probst 1
SHAPIRO BENJAMIN SHAPIRO 1
Mair Lamar Mair 2 Message
TOMS STEVEN TOMS 1

33 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 12/01/17 - 11/30/18

Project Summary/Abstract The ultimate goal of the proposed project is to evaluate and commercialize a combination of proprietary magnet assemblies and magnetic nanoparticles that has been shown in small animal and cadaveric large animal and human studies to improve delivery of medications to the inner ear. Studies using the system (which uses ma...

Phase SBIR

Agency: Department of Health & Human Services
Topic: PAR-16-027
Budget: 08/01/17 - 07/31/18

The company has shown that with by using ultra-fast strong gradients, inexpensive low- field MRI systems can collect images that are comparable in quality (signal-to-noise ratio, resolution) to conventional (e.g., 3T) MRI. The company already has made large strides in commercializing this advantage by conducting human studies (with a prototype) ...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-16-303
Budget: 06/01/17 - 05/31/18

Abstract Glioblastoma multiforme (GBM) is the deadliest form of brain tumor. The current treatment includes a combination of surgical resection, chemotherapy, radiation, and electrical disruption of mitosis has only extended survival to approximately 1 to 2 years. Preliminary pre-clinical findings suggest the potential effectiveness of the candi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 12/05/16 - 11/30/17

Project Summary/Abstract The ultimate goal of the proposed project is to evaluate and commercialize a combination of proprietary magnet assemblies and magnetic nanoparticles that has been shown in small animal and cadaveric large animal and human studies to improve delivery of medications to the inner ear. Studies using the system (which uses ma...

Phase SBIR

Agency: Department of Health & Human Services
Topic: PAR-16-027
Budget: 08/15/16 - 07/31/17

The company has shown that with by using ultra-fast strong gradients, inexpensive low-field MRI systems can collect images that are comparable in quality (signal-to-noise ratio,resolution) to conventional (e.g., 3T) MRI. The company already has made large stridesin commercializing this advantage by conducting human studies (with a prototype) and...

Phase 2 SBIR

Agency: National Institute of Standards and Technology
Topic: 9.01.03
Budget: 08/01/16 - 07/31/18

New shape-engineered iron-based microscopic contrast agents (MCAs) for magnetic resonance imaging promise to increase diagnostic accuracy while reducing side effects, and enhance scientists’ ability to track stem cells. Currently, techniques used for making multispectral microscale contrast agent particles are cost prohibitive. In Phase I, an in...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 06/01/15 - 05/31/16

DESCRIPTION (provided by applicant): Contrast-enhanced MRI has been proven to be a very sensitive modality for the early diagnosis of breast cancer in young women and/or in women with radiographically-dense breasts. The American Cancer Society recommends that high-risk women with lifetime risk greater than 20% should receive annual breast MRI sc...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-14-077
Budget: 06/01/15 - 09/30/15

DESCRIPTION (provided by applicant): This application represents a competing renewal request for a Phase II STTR project, in which we constructed an ultra-fast gradient system for magnetic resonance imaging. Operation of the novel system is based upon the principle that the nervous system is relatively insensitive to very short exposures to chan...

Phase 1 SBIR

Agency: National Institute of Standards and Technology
Topic: 9.01.03.68-R
Budget: 01/01/15 - 12/31/15

Scalable manufacturing of micro-engineered MRI contrast agents has the potential to increase the specificity and resolution of imaging techniques, while reducing morbidity. Currently, techniques used for making such particles are expensive and labor intensive. In Phase I, Weinberg Medical Physics will validate techniques for rapid, massively par...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-13-235
Budget: 08/01/14 - 07/31/15

DESCRIPTION (provided by applicant): The ultimate goal of the proposed project is to evaluate and commercialize a combination of proprietary magnet assemblies and magnetic nanoparticles (initially developed by our University STTR partner), that has been shown in preliminary animal studies to improve delivery of medications to the inner ear. Init...

Load More